Oxygenated derivatives of fatty acids such as leukotrienes (LT), thromboxane (TX), and prostaglandins (PG's) play critical roles in hemostasis, inflammation, immune responses and cellular regulation. Therefore, complete knowledge of their biosynthesis, the enzymes involved and their regulation, interactions, and modes of activities are essential. This proposal is based, in part, on the recent isolation and structural characterization of a novel series of biologically active oxygenated derivatives of arachidonic acid, termed lipoxins (LX). Formed via interactions of the 5- and 15-lipoxygenases, lipoxins display stereospecific activities on human neutrophils (PMN), protein kinase C, microcirculation, and lung strips different than those of PG, TX, or LT's.
The aims of this proposal include the extension of ongoing studies utilizing human PMN as a model to systematically investigate intermediates in the biosynthesis of LX, mechanisms of formation, and to identify their relationship to the formation of other eicosanoids (leukotrienes). Biological activities and products of further transformations of LX will be identified. Stimuli which provoke the oxygenation of both endogenous and exogenous substrates by PMN will be identified, their cellular origins located, and """"""""balanced sheets"""""""" of product formation will be monitored to determine the relationships between PMN functional responses and the generation of mono, di, and trihydroxy fatty acids. Focus will be directed toward evaluating cellular events in the activation of 15-lipoxygenase (LO) and regulation of both the 5- and 15-LO activities of PMN. These PMN activities will be studied in the presence of serum proteins, albumin and other cell types. Cell-cell interactions along the eicosanoid axis will be evaluated in conincubation of PMN with either platelets or vascular cells. These events will also be examined in whole blood. To gain insight into the modes of action of oxygenated fatty acids, PMN functional responses (lysosomal enzyme release, generation of active oxygen species, and Ca2+ mobilization) will be studied. Focus will be on identification of novel products which can regulate cellular activities and the balance of fatty acid remodeling and its temporal relationship to cellular events in the oxygenation of fatty acids and shed light on the interactions between both individual lipoxygenases and cell types. The results of this project should provide a basis for more critical evaluations of the role(s) of oxygenated fatty acids (LT, LX) in complex biological processes.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Zhu, Mingqin; Wang, Xiuzhe; Hjorth, Erik et al. (2016) Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase A?42 Phagocytosis. Mol Neurobiol 53:2733-49
Wang, Xiuzhe; Zhu, Mingqin; Hjorth, Erik et al. (2015) Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement 11:40-50.e1-2
Wang, Chin-Wei; Colas, Romain A; Dalli, Jesmond et al. (2015) Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes. Infect Immun 84:658-65
Hsiao, Hsi-Min; Thatcher, Thomas H; Colas, Romain A et al. (2015) Resolvin D1 Reduces Emphysema and Chronic Inflammation. Am J Pathol 185:3189-201
Spite, Matthew; ClĂ ria, Joan; Serhan, Charles N (2014) Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 19:21-36
Hua, Jing; Jin, Yiping; Chen, Yihe et al. (2014) The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci 55:5944-51
Ramon, Sesquile; Bancos, Simona; Serhan, Charles N et al. (2014) Lipoxin A? modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. Eur J Immunol 44:357-69
Ramon, Sesquile; Baker, Steven F; Sahler, Julie M et al. (2014) The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant? J Immunol 193:6031-40
Norling, Lucy V; Dalli, Jesmond; Flower, Roderick J et al. (2012) Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 32:1970-8
Jones, Caroline N; Dalli, Jesmond; Dimisko, Laurie et al. (2012) Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. Proc Natl Acad Sci U S A 109:20560-5

Showing the most recent 10 out of 38 publications